Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Vaccinations01:51

Vaccinations

Overview
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Probability Laws01:49

Probability Laws

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a Sustainable Care Delivery Payment Model for Children With Medical Complexity.

Hospital pediatrics·2023
Same author

Foreword for clinically integrated networks and the future of primary care.

Current problems in pediatric and adolescent health care·2021
Same author

Children with Medical Complexity.

Pediatric annals·2020
Same author

Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI).

Genetics in medicine : official journal of the American College of Medical Genetics·2020
Same author

Status of legal firearm possession and violent deaths: methods and protocol for a retrospective case-control study.

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2019
Same author

Feeding Tubes in Children With Neurologic Impairment: An Opportunity for Shared Decision-making.

Pediatrics·2019

Related Experiment Video

Updated: Jun 4, 2026

Eye Tracking Young Children with Autism
09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

Booster seat legislation: does it work for all children?

Suzanne N Brixey1, Timothy E Corden, Clare E Guse

  • 1Department of Pediatrics and Injury Research Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53233, USA. sbrixey@mcw.edu

Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention
|February 8, 2011
PubMed
Summary

Booster seat laws increased overall use, but proper use declined in Black and Latino children. Socioeconomic status impacted overall use, not proper use.

More Related Videos

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

Related Experiment Videos

Last Updated: Jun 4, 2026

Eye Tracking Young Children with Autism
09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

Area of Science:

  • Public health
  • Traffic safety research
  • Child passenger safety

Background:

  • Booster seat use is crucial for child passenger safety.
  • Legislation mandating booster seat use aims to improve safety outcomes.
  • Disparities in safety measure adoption across demographics are a concern.

Purpose of the Study:

  • To evaluate the effect of a Wisconsin booster seat law on usage rates.
  • To analyze booster seat use and proper restraint by race, ethnicity, and socioeconomic status.

Main Methods:

  • Longitudinal observational study in Milwaukee County, Wisconsin.
  • Assessed child passengers (4-7 years) before and after booster seat legislation.
  • Conducted direct observations across five distinct time periods.

Main Results:

  • Overall booster seat use rose from 24% to 43%.
  • Proper restraint use increased from 21% to 28% post-legislation.
  • White children showed increased proper use (48% to 68%), while Black children's proper use decreased (18% to 7%), and Latino children's remained stable (10%).
  • Household income affected overall use but not proper use.

Conclusions:

  • Booster seat legislation increased overall use but not necessarily proper use, especially among racial/ethnic minorities.
  • Racial/ethnic minority groups and lower socioeconomic status populations exhibit lower booster seat use and proper use.